Synthetic approaches to 6,6'-disubstituted-2,2'-bipyridine ligands bearing carboxylic acid substituents at the 4,4' or 5,5'-positions are described. Copper(I) complexes with these ligands have been prepared for use in copper-based dye-sensitized solar cells. The single-crystal structures of 6,6'-dimethyl-2,2'-bipyridine-4,4'-dicarboxylic acid (H(2)4), [H(3)6][CF3CO2].2CF3CO2H (H(2)6 = 6,6'-diphenyl-2,2'-bipyridine-4,4'-dicarboxylic acid) and 4[Cu(H(2)2)(H2)].3H2O (H(2)2 = 6,6'-dimethyl-2,2'-bipyridine-5,5'-dicarboxylic acid) are described, as well as those of the intermediates (1E,5E)-1,6-di(2-furyl)hexa-1,5-diene-3,4-dione and 4,4'-di(2-furyl)-6,6'-dimethyl-2,2'-bipyridine (3), and the copper(I) complex [Cu(3)(2)][PF6]. The roles that classical and non-classical hydrogen bonding and pi-stacking interactions play in determining the solid-state packing in these structures are discussed. Preliminary studies of DSCs with these complexes are reported.
No takes yet. Share an insight, caveat, or question.
Constable et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: